TY - JOUR
T1 - Magnetic resonance imaging in pediatric hematology/oncology. Part II. Illustrative cases and assessment of technique
AU - Ringertz, Hans
AU - Ehman, Richard L.
AU - McNamara, Michael T.
AU - Gooding, Charles A.
AU - Brasch, Robert C.
AU - Goldsmith, Michael
N1 - Funding Information:
Supported in part by NIH Grant number RO:AM31937 from the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases and in part by Riksf6reningen mot Cancer 1964-B84-01R. Dr. Ringertz's studies were supported in part by a grant from the Swedish Cancer Society.
PY - 1986
Y1 - 1986
N2 - Preliminary clinical experience with magnetic resonance imaging (MRI) in 28 pediatric patients with 20 different hematological diseases, benign tumors, or malignant neoplasms is presented. The clinical results are presented in the form of case presentations that are discussed in the context of alternative diagnostic imaging modalities. Also discussed are the known biological effects, or lack thereof, the need for sedation, the effect of motion, the effect of MRI on foreign metallic objects, the financial considerations, and the trends for the future, of MRI. This imaging modality has many unique merits. Present difficulties should be overcome by future innovations, making MRI even more efficacious for the diagnosis of blood diseases and cancer in children.
AB - Preliminary clinical experience with magnetic resonance imaging (MRI) in 28 pediatric patients with 20 different hematological diseases, benign tumors, or malignant neoplasms is presented. The clinical results are presented in the form of case presentations that are discussed in the context of alternative diagnostic imaging modalities. Also discussed are the known biological effects, or lack thereof, the need for sedation, the effect of motion, the effect of MRI on foreign metallic objects, the financial considerations, and the trends for the future, of MRI. This imaging modality has many unique merits. Present difficulties should be overcome by future innovations, making MRI even more efficacious for the diagnosis of blood diseases and cancer in children.
UR - http://www.scopus.com/inward/record.url?scp=0022994212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022994212&partnerID=8YFLogxK
U2 - 10.1016/S1040-8428(86)80045-2
DO - 10.1016/S1040-8428(86)80045-2
M3 - Article
C2 - 3779890
AN - SCOPUS:0022994212
SN - 1040-8428
VL - 6
SP - 7
EP - 18
JO - Critical Reviews in Oncology and Hematology
JF - Critical Reviews in Oncology and Hematology
IS - 1
ER -